个性化药物与功能基因组学和药物基因组学的进展。
Advances in Personalized Medicines along with Functional Genomics and Pharmacogenomics.
作者信息
Lee Su-Jun
机构信息
Department of Pharmacology and Pharmacogenomics Research Center, College of Medicine, Inje University, Busan 50834, Korea.
出版信息
J Pers Med. 2021 Sep 22;11(10):941. doi: 10.3390/jpm11100941.
Abstract
State-of-the-art research on the human genome has produced remarkable research achievements in pharmacogenomics and functional genomics, and these research results are making an invaluable contribution to the advancement of personalized medicine [...].
摘要
关于人类基因组的前沿研究在药物基因组学和功能基因组学方面取得了显著的研究成果，这些研究成果正在为个性化医疗的发展做出不可估量的贡献[...]。
相似文献
1
Advances in Personalized Medicines along with Functional Genomics and Pharmacogenomics.个性化药物与功能基因组学和药物基因组学的进展。
J Pers Med. 2021 Sep 22;11(10):941. doi: 10.3390/jpm11100941.
2
Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.个性化医疗、基因组学与药物基因组学：护士入门指南
Clin J Oncol Nurs. 2014 Aug;18(4):437-41. doi: 10.1188/14.CJON.437-441.
3
Promoting synergistic research and education in genomics and bioinformatics.促进基因组学和生物信息学领域的协同研究与教育。
BMC Genomics. 2008;9 Suppl 1(Suppl 1):I1. doi: 10.1186/1471-2164-9-S1-I1.
4
Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece.对希腊医疗保健专业人员关于药物基因组学和个性化医疗观点的批判性评估。
Per Med. 2014 Jan;11(1):15-26. doi: 10.2217/pme.13.92.
5
The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.蛋白质组学在精准医学中的新兴作用：在神经退行性疾病和神经创伤中的应用
Adv Exp Med Biol. 2017;1007:59-70. doi: 10.1007/978-3-319-60733-7_4.
6
Towards structural systems pharmacology to study complex diseases and personalized medicine.迈向用于研究复杂疾病和个性化医疗的结构系统药理学。
PLoS Comput Biol. 2014 May 15;10(5):e1003554. doi: 10.1371/journal.pcbi.1003554. eCollection 2014 May.
7
The Impact of Pharmacogenomics in Personalized Medicine.《药物基因组学在个性化医学中的影响》。
Adv Biochem Eng Biotechnol. 2020;171:369-394. doi: 10.1007/10_2019_110.
8
Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.机构简介：金螺旋生物医学研究所：在药物基因组学和个性化医学方面的跨学科研究和教育活动。
Pharmacogenomics. 2012 Mar;13(4):387-92. doi: 10.2217/pgs.12.7.
9
Genetics and genomics: the scientific drivers of personalized medicine.遗传学与基因组学：个性化医疗的科学驱动力。
Annu Rev Nurs Res. 2011;29:27-54. doi: 10.1891/0739-6686.29.27.
10
Response to "personalized medicine, genomics, and pharmacogenomics".对“个性化医疗、基因组学和药物基因组学”的回应
Clin J Oncol Nurs. 2014 Dec;18(6):618. doi: 10.1188/14.CJON.618.
本文引用的文献
1
Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia.家族性高胆固醇血症中降脂疗法的药物基因组学变异性
J Pers Med. 2021 Aug 31;11(9):877. doi: 10.3390/jpm11090877.
2
Importance of Polymorphisms in Thiopurine Treatments.硫嘌呤治疗中多态性的重要性。
J Pers Med. 2021 Aug 10;11(8):778. doi: 10.3390/jpm11080778.
3
Functional Characterization of 21 Rare Allelic Variants Identified in a Population of 4773 Japanese Individuals by Assessing Phenacetin -Deethylation.通过评估非那西丁去乙基化对4773名日本个体群体中鉴定出的21种罕见等位基因变体进行功能表征。
J Pers Med. 2021 Jul 22;11(8):690. doi: 10.3390/jpm11080690.
4
The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases.UDP-葡萄糖醛酸基转移酶基因变异体的功能及其与药物反应和人类疾病的关联。
J Pers Med. 2021 Jun 14;11(6):554. doi: 10.3390/jpm11060554.
5
Effect of MACC1 Genetic Polymorphisms and Environmental Risk Factors in the Occurrence of Oral Squamous Cell Carcinoma.MACC1基因多态性及环境危险因素在口腔鳞状细胞癌发生中的作用
J Pers Med. 2021 May 31;11(6):490. doi: 10.3390/jpm11060490.
6
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.LINC00673基因变异与口腔癌进展的关联
J Pers Med. 2021 May 25;11(6):468. doi: 10.3390/jpm11060468.
7
Genetic Variants of lncRNA Are Associated with the Clinicopathologic Development of Oral Cancer.长链非编码RNA的基因变异与口腔癌的临床病理发展相关。
J Pers Med. 2021 Apr 26;11(5):348. doi: 10.3390/jpm11050348.
8
The Association of IgE Levels with Genetic Polymorphisms among Asthmatic Patients.哮喘患者中IgE水平与基因多态性的关联
J Pers Med. 2021 Apr 22;11(5):329. doi: 10.3390/jpm11050329.
9
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.一种通过纳入遗传成瘾风险严重程度（GARS）和多巴胺稳态恢复来克服“成瘾大流行”的新型精准方法。
J Pers Med. 2021 Mar 16;11(3):212. doi: 10.3390/jpm11030212.
10
PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics.药物基因组学知识单元（PharmaKU）：一种旨在提高药物基因组学的推广和临床应用的基于网络的工具。
J Pers Med. 2021 Mar 16;11(3):210. doi: 10.3390/jpm11030210.
Zotero 插件